TrialBMC cancer2019

The LACOG-0415 phase II trial: abiraterone acetate and ADT versus apalutamide versus abiraterone acetate and apalutamide in patients with advanced prostate cancer with non-castration testosterone levels.

Gustavo Werutsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.